🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05510830
Starting soon Not applicable

Diagnostic Cervical Conization for Persistent Infection or Integration of HPV

NCT05510830 · tracked via the Priya Life Science China tracker
Sponsor
Tongji Hospital
Phase
Not applicable
Started
2022-10
Last updated
2022-09-08

Condition(s) studied

Human Papilloma Virus InfectionHuman Papilloma Virus IntegrationCervical Intraepithelial NeoplasiaCervical CancerCervical Conization

Investigational drug(s) / intervention(s)

diagnostic cervical conization

diagnostic cervical conization: For the patients who met the inclusion criteria, the gynecologists perform cervical conization and pathological examinations. Then the patients will be followed-up for at least two years with the tests of cervical TCT \& HPV, and colposcopy if necessary. The data will be analyzed and see if the patients with high risk factors benefit from the surgery or not.

Study summary

For the patients with cervical persistent infection or integration of HPV, we has designed a program to perform cervical conization for certain patients to earlier and better diagnose and cure the diseases of HPV infection and related cervical intraepithelial neoplasia/cancer.

Eligibility

Sex
FEMALE
Min age
25 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: 1. The patients are referred to colposcopy and biopsy examinations due to abnormal cervical screening results with no precancerous lesions discovered by pathology. 2. The cervical precancerous lesions are highly suspected by clinicians with one or more following risk factors: * The course of HPV type 16/18 persistent infection is more than two years. * The integration reads of HPV is more than 15. * The impression of colposcopy indicates precancerous lesions. * The cervical TCT indicates ASC-H/HSIL/SCC/AGC-FN/AIS/AC. Exclusion Criteria: 1. Pregnant women. 2. Vaginal intraepithelial neoplasia is highly suspected by colposcopy and pathological examinations. 3. The patients are suffering malignant tumors of other system and have not been cured. 4. There is acute inflammation of the lower genital or anal tract. 5. The patients' health will be severely harmed by the colposcopy and cervical conization due to some circumstances such as severe insufficiency of liver and kidney function, blood diseases and acute inflammation of other systems.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei

More Tongji Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05510830 on ClinicalTrials.gov ↗ ← All trials in China